Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60,773 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Zhao FH, Wu T, Hu YM, Wei LH, Li MQ, Huang WJ, Chen W, Huang SJ, Pan QJ, Zhang X, Hong Y, Zhao C, Li Q, Chu K, Jiang YF, Li MZ, Tang J, Li CH, Guo DP, Ke LD, Wu X, Yao XM, Nie JH, Lin BZ, Zhao YQ, Guo M, Zhao J, Zheng FZ, Xu XQ, Su YY, Zhang QF, Sun G, Zhu FC, Li SW, Li YM, Pan HR, Zhang J, Qiao YL, Xia NS. Zhao FH, et al. Among authors: li mz, li mq, li sw, li ym, li ch, li q. Lancet Infect Dis. 2022 Dec;22(12):1756-1768. doi: 10.1016/S1473-3099(22)00435-2. Epub 2022 Aug 26. Lancet Infect Dis. 2022. PMID: 36037823 Clinical Trial.
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.
Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, Chen W, Huang SJ, Zhao FH, Li MQ, Pan QJ, Zhang X, Li Q, Hong Y, Zhao C, Zhang WH, Li YP, Chu K, Li M, Jiang YF, Li J, Zhao H, Lin ZJ, Cui XL, Liu WY, Li CH, Guo DP, Ke LD, Wu X, Tang J, Gao GQ, Li BY, Zhao B, Zheng FX, Dai CH, Guo M, Zhao J, Su YY, Wang JZ, Zhu FC, Li SW, Pan HR, Li YM, Zhang J, Xia NS. Qiao YL, et al. Among authors: li cg, li mq, li j, li sw, li ym, li rc, li yp, li m, li by, li ch, li q. J Natl Cancer Inst. 2020 Feb 1;112(2):145-153. doi: 10.1093/jnci/djz074. J Natl Cancer Inst. 2020. PMID: 31086947 Free PMC article. Clinical Trial.
Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study.
Yao X, Chen W, Zhao C, Wei L, Hu Y, Li M, Lin Z, Lin B, Liu X, Hong Y, Li Q, Pan Q, Zhang X, Li M, Zhao Y, Zhang L, Xu H, Hu F, Zhao J, Huang Y, Sheng W, Zheng Y, Hu S, Su Y, Huang S, Pan H, Zhao F, Qiao Y, Wu T, Zhang J, Xia N. Yao X, et al. Among authors: li m, li q. Lancet Reg Health West Pac. 2021 Jul 16;13:100196. doi: 10.1016/j.lanwpc.2021.100196. eCollection 2021 Aug. Lancet Reg Health West Pac. 2021. PMID: 34527987 Free PMC article.
Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18.
Chen W, Zhang X, Molijn A, Jenkins D, Shi JF, Quint W, Schmidt JE, Wang P, Liu YL, Li LK, Shi H, Liu JH, Xie X, Niyazi M, Yang P, Wei LH, Li LY, Li J, Liu JF, Zhou Q, Hong Y, Li L, Li Q, Zhou HL, Bian ML, Chen J, Qiao YL, Smith JS. Chen W, et al. Among authors: li lk, li ly, li j, li l, li q. Cancer Causes Control. 2009 Nov;20(9):1705-13. doi: 10.1007/s10552-009-9422-z. Epub 2009 Aug 25. Cancer Causes Control. 2009. PMID: 19705288
[Prevalence of high-risk human papillomavirus and incidence of cervical intraepithelial neoplasia in female populations in Shenzhen, Guangdong Province].
Wu RF, Liu ZH, Zhou QZ, Wulan N, Wang Q, Li Q, Li N, Liu ZH, Shi JF, Li RZ, Zhang CH, Zhou YQ, Liu B, Weng LM, Qiao YL. Wu RF, et al. Among authors: li n, li rz, li q. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Feb;32(1):90-5. doi: 10.3881/j.issn.1000-503X.2010.01.021. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010. PMID: 20236596 Chinese.
60,773 results
You have reached the last available page of results. Please see the User Guide for more information.